HK1244000B - 多環氨基甲酰吡啶酮化合物及其藥物用途 - Google Patents
多環氨基甲酰吡啶酮化合物及其藥物用途Info
- Publication number
- HK1244000B HK1244000B HK18103442.8A HK18103442A HK1244000B HK 1244000 B HK1244000 B HK 1244000B HK 18103442 A HK18103442 A HK 18103442A HK 1244000 B HK1244000 B HK 1244000B
- Authority
- HK
- Hong Kong
- Prior art keywords
- polycyclic
- pharmaceutical use
- carbamoylpyridone compounds
- carbamoylpyridone
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462096291P | 2014-12-23 | 2014-12-23 | |
PCT/US2015/067155 WO2016106237A1 (en) | 2014-12-23 | 2015-12-21 | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1244000B true HK1244000B (zh) | 2020-05-22 |
Family
ID=55168426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103442.8A HK1244000B (zh) | 2014-12-23 | 2018-03-12 | 多環氨基甲酰吡啶酮化合物及其藥物用途 |
Country Status (24)
Country | Link |
---|---|
US (4) | US9522912B2 (zh) |
EP (2) | EP3237416B1 (zh) |
JP (3) | JP6393835B2 (zh) |
KR (4) | KR102020004B1 (zh) |
CN (2) | CN107108643B (zh) |
AR (1) | AR103251A1 (zh) |
AU (3) | AU2015369817B2 (zh) |
BR (1) | BR102015032109A2 (zh) |
CA (1) | CA2969244C (zh) |
EA (1) | EA201791019A1 (zh) |
ES (1) | ES2732482T3 (zh) |
HK (1) | HK1244000B (zh) |
IL (1) | IL252532A0 (zh) |
MA (1) | MA45613A (zh) |
MX (1) | MX2017007814A (zh) |
NZ (1) | NZ732391A (zh) |
PL (1) | PL3237416T3 (zh) |
PT (1) | PT3237416T (zh) |
SG (1) | SG11201704421QA (zh) |
SI (1) | SI3237416T1 (zh) |
TR (1) | TR201909152T4 (zh) |
TW (2) | TWI695003B (zh) |
UY (1) | UY36465A (zh) |
WO (1) | WO2016106237A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY191741A (en) | 2012-12-21 | 2022-07-13 | Gilead Sciences Inc | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
HUE056470T2 (hu) | 2014-12-26 | 2022-02-28 | Univ Emory | Vírusellenes N4-Hidroxicitidin származékok |
PL3277691T3 (pl) * | 2015-04-02 | 2019-07-31 | Gilead Sciences, Inc. | Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
US11939320B2 (en) | 2017-11-02 | 2024-03-26 | Abbvie Inc. | Modulators of the integrated stress pathway |
EP3704091A1 (en) * | 2017-11-02 | 2020-09-09 | Calico Life Sciences LLC | Modulators of the integrated stress pathway |
GB2590198B (en) | 2017-12-07 | 2022-02-23 | Univ Emory | N4-hydroxycytidine derivatives and anti-viral uses related thereto |
EP3723751A4 (en) * | 2017-12-08 | 2021-07-07 | The Rockefeller University | PYRANO [3,4-B] PYRAZIN-KAPPA-OPIOID RECEPTOR LIGANDS FOR THE TREATMENT OF ADDICTION, PRURITUS, PAIN AND INFLAMMATION |
EP3805221A4 (en) | 2018-05-31 | 2022-01-05 | Shionogi & Co., Ltd | POLYCYCLIC PYRIDONE DERIVATIVE |
PE20210477A1 (es) * | 2018-05-31 | 2021-03-11 | Shionogi & Co | Derivado policiclico de carbamoilpiridona |
UA127822C2 (uk) | 2019-03-22 | 2024-01-10 | Гіліад Сайєнсіз, Інк. | Місткові трициклічні карбамоїлпіридонові сполуки та їх фармацевтичне застосування |
WO2021093846A1 (zh) * | 2019-11-13 | 2021-05-20 | 上海拓界生物医药科技有限公司 | 新型四环杂环化合物及其药物用途 |
WO2021107065A1 (ja) * | 2019-11-28 | 2021-06-03 | 塩野義製薬株式会社 | 多環性ピリドピラジン誘導体 |
JPWO2021107066A1 (zh) | 2019-11-28 | 2021-06-03 | ||
US11697652B2 (en) | 2020-02-24 | 2023-07-11 | Gilead Sciences, Inc. | Tetracyclic compounds and uses thereof |
SI4196479T1 (sl) | 2021-01-19 | 2024-01-31 | Gilead Sciences, Inc. | Substituirane piridotriazinske spojine in njihove uporabe |
CN114736173A (zh) * | 2022-05-24 | 2022-07-12 | 无锡捷化医药科技有限公司 | 一种3-(二氟甲基)氧杂环丁烷-3-胺盐酸盐的制备方法 |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5922695A (en) | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
US5935946A (en) | 1997-07-25 | 1999-08-10 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
GB2345058A (en) | 1998-12-01 | 2000-06-28 | Cerebrus Pharm Ltd | Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system |
IL143958A0 (en) | 1998-12-25 | 2002-04-21 | Shionogi & Co | Heteroaromatic derivatives having an inhibitory activity against hiv integrase |
AU2001262732A1 (en) | 2000-06-14 | 2001-12-24 | Shionogi And Co., Ltd. | Inhibitor for enzyme having two divalent metal ions as active centers |
WO2003016275A1 (en) | 2001-08-10 | 2003-02-27 | Shionogi & Co., Ltd. | Antiviral agent |
US20050004180A1 (en) | 2001-10-03 | 2005-01-06 | ZOU Dong | Pyrrolidinone derivatives |
RS51542B (sr) | 2001-10-26 | 2011-06-30 | Istituto Di Ricerche Di Biologia Molecolare P.Angeletti Spa. | N-supstituisani hidroksipirimidinon karboksamidni inhibitori hiv integraze |
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
JP2006506352A (ja) | 2002-09-11 | 2006-02-23 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害剤として有用なジヒドロキシピリドピラジン−1,6−ジオン化合物 |
SI1564210T1 (sl) | 2002-11-20 | 2010-01-29 | Japan Tobacco Inc | 4-oksokinolinske spojine in njihova uporaba kot inhibitorji HIV integraze |
EP1566049A4 (en) * | 2002-11-26 | 2006-05-03 | Ambient Corp | ARRANGEMENT OF AN INDUCTIVE COUPLER FOR POWER SUPPLY COMMUNICATION |
ES2308136T3 (es) | 2003-01-14 | 2008-12-01 | Gilead Sciences, Inc. | Composiciones y procedimientos para la politerapia antiviral. |
PT1628685E (pt) | 2003-04-25 | 2011-03-16 | Gilead Sciences Inc | Análogos de fosfonatos antivirais |
TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
TW200528440A (en) | 2003-10-31 | 2005-09-01 | Fujisawa Pharmaceutical Co | 2-cyanopyrrolidinecarboxamide compound |
US20070155744A1 (en) | 2004-01-30 | 2007-07-05 | Istituto Di Ricerche Di Biologia Molecolare P, Angeletti S.P.A. | N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors |
WO2005086700A2 (en) | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
WO2005110414A2 (en) | 2004-05-07 | 2005-11-24 | Merck & Co., Inc. | Hiv integrase inhibitors |
US7273859B2 (en) | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
MY134672A (en) | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
US7531554B2 (en) | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
EP1758581A1 (en) | 2004-05-21 | 2007-03-07 | Japan Tobacco, Inc. | Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
ME01945B (me) | 2004-07-27 | 2011-12-31 | Gilead Sciences Inc | Nukleozid-fosfonatni konjugati kao sredstva protiv hiv-a |
JP4953297B2 (ja) | 2004-09-15 | 2012-06-13 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体 |
CA2634499A1 (en) | 2004-12-23 | 2006-06-29 | Virochem Pharma Inc. | Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
US7858788B2 (en) | 2005-02-21 | 2010-12-28 | Shionogi & Co., Ltd. | Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
EA014162B1 (ru) | 2005-04-28 | 2010-10-29 | Смитклайн Бичем Корпорейшн | Полициклическое карбамоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич |
US20060249072A1 (en) * | 2005-05-05 | 2006-11-09 | Csillag Frank J | Method of synthesizing a fluoride growth material for improved outgassing |
EP1888581A2 (en) | 2005-05-16 | 2008-02-20 | Gilead Sciences, Inc. | Hiv-integrase inhibitor compounds |
EP1906971A2 (en) | 2005-07-27 | 2008-04-09 | Gilead Sciences, Inc. | Antiviral compounds |
AU2006307101A1 (en) * | 2005-10-27 | 2007-05-03 | Shionogi & Co., Ltd. | Polycyclic carbamoylpyridone derivative having inhibitory activity on HIV integrase |
KR20140082858A (ko) | 2005-12-30 | 2014-07-02 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 인테그라제 억제제의 약동학을 개선하기 위한 방법 |
WO2007089030A1 (en) | 2006-02-01 | 2007-08-09 | Japan Tobacco Inc. | Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
CN101437801B (zh) | 2006-03-06 | 2013-02-06 | 日本烟草产业株式会社 | 制备4-氧代喹啉化合物的方法 |
EA017861B9 (ru) | 2006-03-06 | 2014-05-30 | Джапан Тобакко Инк. | Способ получения 4-оксохинолинового соединения |
US7893055B2 (en) * | 2006-06-28 | 2011-02-22 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
CA2657034A1 (en) | 2006-07-19 | 2008-01-24 | University Of Georgia Research Foundation, Inc. | Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
TWI411602B (zh) | 2006-09-12 | 2013-10-11 | Gilead Sciences Inc | 製造整合酶抑制劑的方法及彼所用的中間物 |
WO2008048538A1 (en) | 2006-10-18 | 2008-04-24 | Merck & Co., Inc. | Hiv integrase inhibitors |
BRPI0807581A2 (pt) | 2007-02-23 | 2014-07-01 | Gilead Science Inc | Moduladores de propriedades farmacocinéticas de produtos terapêuticos |
US20080280945A1 (en) | 2007-05-09 | 2008-11-13 | Sachin Lohani | Crystalline forms of an HIV integrase inhibitor |
WO2009006203A1 (en) | 2007-06-29 | 2009-01-08 | Gilead Sciences, Inc. | Therapeutic compositions and the use thereof |
NZ582086A (en) | 2007-06-29 | 2012-07-27 | Gilead Sciences Inc | Therapeutic compositions and the use thereof |
US20090012103A1 (en) * | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
EP2757096A1 (en) | 2007-11-16 | 2014-07-23 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
US8129398B2 (en) | 2008-03-19 | 2012-03-06 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US20100272811A1 (en) | 2008-07-23 | 2010-10-28 | Alkermes,Inc. | Complex of trospium and pharmaceutical compositions thereof |
EP2660239B1 (en) | 2008-07-25 | 2016-11-23 | VIIV Healthcare Company | Chemical compounds as synthetic intermediates |
WO2010011819A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
SI2320908T1 (sl) | 2008-07-25 | 2014-05-30 | Viiv Healthcare Company | Predzdravila dolutegravirja |
WO2010011818A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
ES2449752T3 (es) | 2008-07-25 | 2014-03-21 | Viiv Healthcare Company | Proceso para la preparación de un derivado de pirido[1,2-a]pirrolo[1',2':3,4]imidazo[1,2-d]piracin-8-carboxamida |
WO2010011815A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
CA2744019C (en) | 2008-12-11 | 2017-03-14 | Shionogi & Co., Ltd. | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
JP2012512246A (ja) * | 2008-12-17 | 2012-05-31 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | C環修飾型三環式ベンゾナフチリジノン・タンパク質キナーゼ阻害薬及びこれらの使用 |
TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
US8338441B2 (en) | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
EA025176B1 (ru) | 2010-01-27 | 2016-11-30 | Вайв Хелткер Компани | Комбинация для лечения вич-инфекции |
EP2540720B1 (en) | 2010-02-26 | 2015-04-15 | Japan Tobacco, Inc. | 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Viiv醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
US20130165489A1 (en) | 2010-05-03 | 2013-06-27 | The Trustees Of The University Of Pennsylvania | Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof |
KR20130135826A (ko) | 2010-07-02 | 2013-12-11 | 길리애드 사이언시즈, 인코포레이티드 | Aids를 치료하기 위한 나프트-2-일아세트산 유도체 |
NZ604716A (en) | 2010-07-02 | 2014-12-24 | Gilead Sciences Inc | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
CN106083891B (zh) | 2010-08-05 | 2018-03-23 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的化合物的制造方法 |
SI2620436T1 (en) * | 2010-09-24 | 2018-08-31 | Shionogi & Co., Ltd. | A prodrug substituted polycyclic carbamoyl pyridone derivative |
ES2707997T3 (es) | 2011-04-21 | 2019-04-08 | Gilead Sciences Inc | Compuestos de benzotiazol y su uso farmacéutico |
US20140213553A1 (en) | 2011-05-03 | 2014-07-31 | Concert Pharmaceuticals Inc. | Carbamoylpyridone derivatives |
WO2012151567A1 (en) | 2011-05-05 | 2012-11-08 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for preventing and treating influenza |
CA2840095A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
ES2613180T3 (es) | 2011-09-14 | 2017-05-23 | Mapi Pharma Limited | Forma amorfa de la sal sódica dolutegravir |
AU2012321762A1 (en) | 2011-10-12 | 2014-04-17 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase-inhibiting activity |
WO2013091096A1 (en) | 2011-12-20 | 2013-06-27 | Boehringer Ingelheim International Gmbh | Condensed triclyclic compounds as inhibitors of hiv replication |
US9284323B2 (en) * | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
NZ622769A (en) | 2012-04-20 | 2017-06-30 | Gilead Sciences Inc | Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection |
WO2014008636A1 (en) | 2012-07-11 | 2014-01-16 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as hiv integrase inhibitors |
EP2875024A4 (en) | 2012-07-20 | 2015-12-23 | Merck Sharp & Dohme | HIV TREATMENT WITH AMIDOSUBSTITUTED PYRIMIDINONE DERIVATIVES |
US20150218164A1 (en) | 2012-07-25 | 2015-08-06 | Merck Sharp & Dohme Corp. | Substituted naphthyridinedione derivatives as hiv integrase inhibitors |
IN2015DN01688A (zh) | 2012-08-03 | 2015-07-03 | Gilead Sciences Inc | |
KR20150093819A (ko) | 2012-12-14 | 2015-08-18 | 글락소스미스클라인 엘엘씨 | 약제 조성물 |
WO2014099586A1 (en) | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
MY191741A (en) * | 2012-12-21 | 2022-07-13 | Gilead Sciences Inc | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
US20140221355A1 (en) | 2012-12-21 | 2014-08-07 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
EP2934482A4 (en) | 2012-12-21 | 2016-07-20 | Merck Sharp & Dohme | ADMINISTRATIVE FORMULATIONS |
MX2015008467A (es) | 2012-12-27 | 2015-09-23 | Japan Tobacco Inc | Derivado sustituido de espiropirido[1,2-a]pirazina y uso medico del mismo como inhibidor de la integrasa del virus de inmunodeficiencia humana. |
US9493479B2 (en) * | 2013-04-16 | 2016-11-15 | Merck Sharp & Dohme Corp. | Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors |
US9951079B2 (en) * | 2013-06-13 | 2018-04-24 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as HIV integrase inhibitors |
WO2015039348A1 (en) | 2013-09-23 | 2015-03-26 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors |
AP2016009157A0 (en) | 2013-09-27 | 2016-04-30 | Merck Sharp & Dohme | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
WO2015089847A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrase inhibitors |
TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
PL3277691T3 (pl) * | 2015-04-02 | 2019-07-31 | Gilead Sciences, Inc. | Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne |
-
2015
- 2015-12-10 TW TW104141539A patent/TWI695003B/zh active
- 2015-12-10 TW TW109115099A patent/TWI738321B/zh active
- 2015-12-21 WO PCT/US2015/067155 patent/WO2016106237A1/en active Application Filing
- 2015-12-21 KR KR1020197013162A patent/KR102020004B1/ko active IP Right Grant
- 2015-12-21 US US14/977,347 patent/US9522912B2/en active Active
- 2015-12-21 BR BR102015032109A patent/BR102015032109A2/pt not_active Application Discontinuation
- 2015-12-21 MA MA045613A patent/MA45613A/fr unknown
- 2015-12-21 PL PL15825729T patent/PL3237416T3/pl unknown
- 2015-12-21 SI SI201530743T patent/SI3237416T1/sl unknown
- 2015-12-21 KR KR1020177020150A patent/KR101978167B1/ko active IP Right Grant
- 2015-12-21 MX MX2017007814A patent/MX2017007814A/es unknown
- 2015-12-21 CN CN201580070876.6A patent/CN107108643B/zh active Active
- 2015-12-21 CA CA2969244A patent/CA2969244C/en active Active
- 2015-12-21 UY UY0001036465A patent/UY36465A/es not_active Application Discontinuation
- 2015-12-21 EP EP15825729.5A patent/EP3237416B1/en active Active
- 2015-12-21 KR KR1020197025726A patent/KR102240584B1/ko active IP Right Grant
- 2015-12-21 PT PT15825729T patent/PT3237416T/pt unknown
- 2015-12-21 TR TR2019/09152T patent/TR201909152T4/tr unknown
- 2015-12-21 ES ES15825729T patent/ES2732482T3/es active Active
- 2015-12-21 CN CN202010421213.7A patent/CN111454273A/zh active Pending
- 2015-12-21 KR KR1020217010577A patent/KR20210042185A/ko not_active Application Discontinuation
- 2015-12-21 EP EP18173776.8A patent/EP3388431A1/en active Pending
- 2015-12-21 EA EA201791019A patent/EA201791019A1/ru unknown
- 2015-12-21 SG SG11201704421QA patent/SG11201704421QA/en unknown
- 2015-12-21 AU AU2015369817A patent/AU2015369817B2/en active Active
- 2015-12-21 JP JP2017531320A patent/JP6393835B2/ja active Active
- 2015-12-21 NZ NZ732391A patent/NZ732391A/en not_active IP Right Cessation
- 2015-12-22 AR ARP150104261A patent/AR103251A1/es unknown
-
2016
- 2016-11-11 US US15/349,353 patent/US9795602B2/en active Active
-
2017
- 2017-05-25 IL IL252532A patent/IL252532A0/en unknown
- 2017-09-14 US US15/704,842 patent/US10646486B2/en active Active
-
2018
- 2018-03-12 HK HK18103442.8A patent/HK1244000B/zh unknown
- 2018-07-20 JP JP2018136915A patent/JP6934846B2/ja active Active
-
2019
- 2019-01-22 AU AU2019200422A patent/AU2019200422B2/en active Active
-
2020
- 2020-01-07 JP JP2020000897A patent/JP2020073560A/ja active Pending
- 2020-03-27 US US16/832,230 patent/US20210015816A1/en not_active Abandoned
- 2020-12-10 AU AU2020286299A patent/AU2020286299B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1244000B (zh) | 多環氨基甲酰吡啶酮化合物及其藥物用途 | |
HK1249103B (zh) | 多環氨甲醯基吡啶酮化合物及其藥物用途 | |
HK1243073A1 (zh) | 治療性化合物及其用途 | |
GB201403093D0 (en) | Therapeutic compounds and their use | |
IL283335B (en) | Dihydropyrimidine-2-one compounds and their medical use | |
HK1232211A1 (zh) | 二甲基吡啶胺衍生物及其醫藥用途 | |
ZA201701492B (en) | Pyrazolothiazole compound and medicine | |
GB201702464D0 (en) | Pharmaceutical agent | |
GB201406115D0 (en) | New pharmaceutical use | |
GB201517133D0 (en) | New pharmaceutical use | |
GB201409662D0 (en) | New pharmaceutical use | |
GB201616767D0 (en) | New pharmaceutical use | |
GB201517454D0 (en) | New pharmaceutical use | |
GB201517132D0 (en) | New pharmaceutical use | |
GB201508613D0 (en) | New pharmaceutical use | |
GB201508611D0 (en) | New pharmaceutical use | |
GB201507813D0 (en) | New pharmaceutical use | |
GB201410387D0 (en) | Compounds and their therapeutic use | |
GB201403496D0 (en) | Compounds and their therapeutic use | |
GB201413411D0 (en) | Novel compounds and their use |